Acasti Pharma, Inc. News Headlines

ACST 
$0.5201
*  
0.0217
4.01%
Get ACST Alerts
*Delayed - data as of Oct. 23, 2014  -  Find a broker to begin trading ACST now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Tuesday Sector Laggards: Diagnostics, Education & Training Services
10/14/2014 4:03:56 PM - BNK Invest


Acasti Pharma Reports Positive Data From PK Trial Of CaPre - Quick Facts
9/30/2014 8:17:00 AM - RTT News


Acasti Pharma Reports Positive Data From PK Trial Of CaPre - Quick Facts
9/30/2014 8:17:00 AM - RTT News


CaPre Phase 2 trial hits all endpoints
9/30/2014 7:46:00 AM - Seeking Alpha


SLXP Gets FDA Nod, Catalyst Makes Right Moves, TKAI On Watch, AMAG Opens Wallet
9/30/2014 1:08:00 AM - RTT News


SLXP Gets FDA Nod, Catalyst Makes Right Moves, TKAI On Watch, AMAG Opens Wallet
9/30/2014 1:08:00 AM - RTT News


Roadmap Capital's Hugh Cleland And Stephen Ireland: Due Diligence Rules In Biotech Investment
9/18/2014 3:08:00 PM - Seeking Alpha


Mallinckrodt Beats on Q3 Earnings and Revenues, Ups View - Analyst Blog
8/13/2014 1:23:00 PM - Zacks.com


Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
7/24/2014 9:46:00 AM - Zacks.com


Acasti Pharma Inc. (ACST) Jumps: Stock Rises 7.6% - Tale of the Tape
7/10/2014 9:21:00 AM - Zacks.com


Acasti Pharma (ACST) Soars: Stock Adds 10.0% in Session - Tale of the Tape
6/16/2014 9:18:00 AM - Zacks.com


Activist Trying To Unlock A Potential 65% Upside In Neptune
4/15/2014 8:57:00 AM - Seeking Alpha


Acasti Pharma: An Undervalued Biotech With A Potential Best-In-Class Omega-3 Drug
4/1/2014 8:27:00 AM - Seeking Alpha


Wednesday Sector Leaders: General Contractors & Builders, Diagnostics
3/19/2014 1:15:31 PM - BNK Invest


Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High
2/21/2014 10:00:00 AM - Seeking Alpha


Neptune Erecting A Moat In Omega-3; Shares Undervalued
1/21/2014 11:46:00 AM - Seeking Alpha


While Amarin Continues To Go Rancid, Neptune Will Soar
1/11/2014 8:34:00 AM - Seeking Alpha


Healthcare Stocks Falling; Neptune Tech, Subsidiary Settle Patent Fight with Aker BioMarine Over Krill Oil Technology
12/17/2013 3:05:49 PM - MT Newswires


Sector Update: Healthcare
12/17/2013 3:02:46 PM - MT Newswires


Acasti Pharma: Increasing Investor Interest And Volatility Likely Cometh
7/9/2013 2:28:00 PM - Seeking Alpha


Small-Cap Biotechs With Blockbuster Potential: Hugh Cleland
7/9/2013 5:10:00 AM - Seeking Alpha


5 'Red Hot' Biotechs: Chen Lin
7/3/2013 5:38:00 PM - Seeking Alpha


Krill Oil's Omega-3s And CaPre: Brought To You By Acasti
4/3/2013 3:58:00 AM - Seeking Alpha


3 Speculative Healthcare Companies With High Levels Of Insider Ownership - Part III
3/26/2013 11:36:00 AM - Seeking Alpha


Amarin: The More You Know The Fishier It Gets
2/27/2013 12:59:00 AM - Seeking Alpha